Drug Search Results
More Filters [+]

Sufugolix

Alternative Names: sufugolix
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: GnRH Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sufugolix

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Endometriosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2004-003829-28

P2

Completed

Endometriosis

2005-08-31

2004-001721-13

P3

Unknown status

Endometriosis

None

Recent News Events

Date

Type

Title